Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Symptoms include dizziness, weakness, confusion, and irritability
In a clinical analysis of over 300 patients, people saw an average total body weight loss (TBWL) of: 5.7% at 3 months 9.7% at 6 months 12.7% at 9 months 13.4% at 12 months About 22% of patients lost 20% or more of their body weight by the one-year mark
Freezing is listed as not recommended because it can damage the peptide structure, and the storage table says to keep the medication above 2 degrees Celsius
Kidney Function Dehydration from severe nausea and vomiting could potentially affect kidney function
investigation may impact future claims and product labeling discussions in the U.S
Tirzepatide was initially approved for use in treating type 2 diabetes
US$ 21.38
US$ 29.10
US$ 21.41
US$ 24.59
US$ 27.20
